Breaking News

AMRI, GE Healthcare Extend Supply Pact

December 6, 2012

Will supply ABA product from Rensselaer facility

AMRI has extended a commercial supply agreement with GE Healthcare for Aminobisamide Hydrochloride (ABA), through December 31, 2016. AMRI will supply ABA, an intermediate material used in diagnostic imaging agents to GE. Production will continue at AMRI's large scale manufacturing subsidiary in Rensselaer, NY. The new contract replaces the existing supply contract initiated in 2005.
 
"We are pleased to once again extend our long-term relationship with GE Healthcare," said AMRI chairman, chief executive officer and president, Thomas E. D'Ambra, Ph.D. "The renewal of this relationship underscores the confidence that premier global pharmaceutical and health care companies have in AMRI's ability to meet their critical product needs."
 
"The ABA product relationship with GE Healthcare has been an important one for AMRI since acquisition of the Rensselaer plant in 2003 and at this time is our largest commercial supply arrangement. We continue to be pleased with the progress that we are making in our Large Scale Manufacturing business segment, the largest component of which is our Rensselaer site. The extension of this key, long term agreement provides a consistent and high quality revenue source for this business unit through 2016."

Related Contract Manufacturing:

Related Packaging:

Related Compliance:

  • Packaging Equipment Technology Preview

    Packaging Equipment Technology Preview

    February 15, 2017
    Today’s complex drug products present challenges; the latest equipment capabilities help overcome them

  • The Good, the Bad, and the Donald

    The Good, the Bad, and the Donald

    January 31, 2017
    Orphan drugs, CMO continuous manufacturing and developing world sales offer biggest revenue opportunities

  • Predictive Analytics and the Future of RBM

    Rajneesh Patil, Senior Director, RBM and Analytics, QuintilesIMS||January 23, 2017
    How advances in Risk-Based Monitoring will enable a more proactive approach to identify and mitigate potential risks